ClinicalTrials.gg
Not yet recruitingNCT07941596Updated Nov 17, 2026

Screen Time Exposure and Behavioral Outcomes

An observational study in Screen Time Exposure and Behavioral Outcomes, sponsored by Sohag University. Not yet recruiting at 1 site in Egypt. Open to participants aged 2 Years to 5 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-11-17.

Sponsored by Sohag University · Observational

Updated Nov 17, 2026Newly registeredGo to Updates ↓

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Study type
Observational
Model
Other
Time perspective
Cross-sectional
Enrollment
600
Ages
2 Years to 5 Years
Sex
All
01

Study summary

The aim of the study is to assess the association between screen time and behavioral difficulties among preschool- aged children

Objectives of the study:

  • To detect the daily duration of screen time among preschool - aged children.
  • To detect behavioral difficulties among preschool-aged children.
  • To detect the association between screen time and behavioral difficulties.

Study population and and Locality:

This cross-sectional study will be conducted among primary caregivers of preschool-aged children attending the outpatient pediatric clinic at Sohag East Primary mother and children care unit in Sohag Governorate, Egypt that serves wide catchment area from Sohag city and surrounding villages. Data collection will take place over a period of six months. All caregivers who meet the predetermined eligibility criteria and provide written informed consent will be invited to participate in the study. A total coverage sampling approach will be employed to recruit eligible participants during the study period.

02

Conditions studied

  • Screen Time Exposure and Behavioral Outcomes
03

In context

Lead sponsor

Sohag University is the lead sponsor of 1,235 studies on the registry; 639 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
2 Years to 5 Years
Sexes eligible
All
Accepts healthy volunteers
Yes
Sampling method
Non-probability sample

Study population

This cross-sectional study will be conducted among primary caregivers of preschool-aged children attending the outpatient pediatric clinic at Sohag East Primary mother and children care unit in Sohag Governorate, Egypt that serves wide catchment area from Sohag city and surrounding villages. Data collection will take place over a period of six months. All caregivers who meet the predetermined eligibility criteria and provide written informed consent will be invited to participate in the study. A total coverage sampling approach will be employed to recruit eligible participants during the study period

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Children will be eligible for participation if they fulfill all of the following criteria:

    1. Children aged 2-5 years.
    2. Children whose parent/primary caregiver provides written for participation.
    3. Children whose parent/primary caregiver has lived with and cared for the child sufficiently long enough to provide reliable information about the child's daily screen-time exposure and behavior.

Exclusion criteria

Exclusion Criteria:

Children will be excluded if they have:

<!-- -->

  1. Previously diagnosed neurodevelopmental disorders, such as:

    • Autism spectrum disorder
    • Intellectual disability
    • Global developmental delay
    • Significant developmental language disorder
  2. Previously diagnosed major neurological disorders that could independently affect behavior or development.
  3. Known severe hearing or visual impairment that could interfere with behavioral assessment.
  4. Children whose parents/caregiver refuse participation.
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

05

Study design

Observational model
Other
Time perspective
Cross-sectional
Enrollment
600 participants (estimated)
Patient registry
No

Interventions

  • OtherNo intervention (observational study)

    This is an observational study, data will be prospectively collected

  • OtherObservational

    Data will be collected using a structured questionnaire during regular clinic visits to evaluate the clinical outcomes and demographic characteristics of the participants without modifying their prescribed treatment

06

What researchers measure

Primary outcomes

  1. to assess the association between screen time and behavioral difficulties among preschool- aged children.

    Data will be collected through personal interviews using validated questionnaire. The questionnaire

    Time frame: 3 months

07

Study locations

1 site
08

References and documents

Individual participant data

Plan to share: No — Individual participant data will not be shared to protect patient privacy and confidentiality

No publications or documents are linked to this record.

09

Timeline

1 registry update since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reached

Start is estimated for Dec 2026; primary completion for Mar 2027, 3 months later.

How these figures are worked out, and which studies are left out of them.

Registered
Nov 11, 2026
First posted
Nov 17, 2026
StartEst.
Dec 1, 2026
Primary completionEst.
Mar 2027
CompletionEst.
Mar 2027
Last update
Nov 17, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Registered
First appeared on the registry. No changes since
Nov 17, 2026
Show all 1 update
  1. Nov 17, 2026
    First appeared on the registry

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT07941596
Lead sponsor
Sohag University
Responsible party
Heba Salah Eldeen Elsayed (Family Medicine Specialist, Sohag University) — Principal investigator
First posted
Nov 17, 2026
Start date
Dec 1, 2026 (estimated)
Primary completion
Mar 2027 (estimated)
Completion
Mar 2027 (estimated)
Last update
Nov 17, 2026

Study contacts

Heba ELsayed, MSc
Contact
heba_salaheldien_post@med.sohag.edu.eg
00201112634925
Ayat Ahmed, MD
principal investigator · Sohag University

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Nov 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion